Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients.
Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients.
复制标题
DOI:
10.1016/j.heliyon.2022.e10166
复制
发表时间:
2022-08
期刊:
影响因子:
4
通讯作者:
Taouli, Bachir
中科院分区:
文献类型:
--
作者:
Carbonell, Guillermo;Del Valle, Diane Marie;Gonzalez-Kozlova, Edgar;Marinelli, Brett;Klein, Emma;El Homsi, Maria;Stocker, Daniel;Chung, Michael;Bernheim, Adam;Simons, Nicole W.;Xiang, Jiani;Nirenberg, Sharon;Kovatch, Patricia;Lewis, Sara;Merad, Miriam;Gnjatic, Sacha;Taouli, Bachir
Despite extraordinary international efforts to dampen the spread and understand the mechanisms behind SARS-CoV-2 infections, accessible predictive biomarkers directly applicable in the clinic are yet to be discovered. Recent studies have revealed that diverse types of assays bear limited predictive power for COVID-19 outcomes. Here, we harness the predictive power of chest computed tomography (CT) in combination with plasma cytokines using a machine learning and k-fold cross-validation approach for predicting death during hospitalization and maximum severity degree in COVID-19 patients. Patients (n = 152) from the Mount Sinai Health System in New York with plasma cytokine assessment and a chest CT within five days from admission were included. Demographics, clinical, and laboratory variables, including plasma cytokines (IL-6, IL-8, and TNF-α), were collected from the electronic medical record. We found that CT quantitative alone was better at predicting severity (AUC 0.81) than death (AUC 0.70), while cytokine measurements alone better-predicted death (AUC 0.70) compared to severity (AUC 0.66). When combined, chest CT and plasma cytokines were good predictors of death (AUC 0.78) and maximum severity (AUC 0.82). Finally, we provide a simple scoring system (nomogram) using plasma IL-6, IL-8, TNF-α, ground-glass opacities (GGO) to aerated lung ratio and age as new metrics that may be used to monitor patients upon hospitalization and help physicians make critical decisions and considerations for patients at high risk of death for COVID-19. Radiology; Chest CT; Cytokines; COVID-19; SARS-CoV-2.
登录
查看更多内容
影响因子:
2.1
作者:
Avila RS;Fain SB;Hatt C;Armato SG 3rd;Mulshine JL;Gierada D;Silva M;Lynch DA;Hoffman EA;Ranallo FN;Mayo JR;Yankelevitz D;Estepar RSJ;Subramaniam R;Henschke CI;Guimaraes A;Sullivan DC
通讯作者:
Sullivan DC
影响因子:
5.9
作者:
Lanza, Ezio;Muglia, Riccardo;Balzarini, Luca
通讯作者:
Balzarini, Luca
影响因子:
16.6
作者:
Feng Z;Yu Q;Yao S;Luo L;Zhou W;Mao X;Li J;Duan J;Yan Z;Yang M;Tan H;Ma M;Li T;Yi D;Mi Z;Zhao H;Jiang Y;He Z;Li H;Nie W;Liu Y;Zhao J;Luo M;Liu X;Rong P;Wang W
通讯作者:
Wang W
影响因子:
82.9
作者:
Del Valle DM;Kim-Schulze S;Huang HH;Beckmann ND;Nirenberg S;Wang B;Lavin Y;Swartz TH;Madduri D;Stock A;Marron TU;Xie H;Patel M;Tuballes K;Van Oekelen O;Rahman A;Kovatch P;Aberg JA;Schadt E;Jagannath S;Mazumdar M;Charney AW;Firpo-Betancourt A;Mendu DR;Jhang J;Reich D;Sigel K;Cordon-Cardo C;Feldmann M;Parekh S;Merad M;Gnjatic S
通讯作者:
Gnjatic S
DOI:
10.1007/s11547-020-01291-y
发表时间:
2021-03
期刊:
La Radiologia medica
影响因子:
--
作者:
Caruso D;Polici M;Zerunian M;Pucciarelli F;Polidori T;Guido G;Rucci C;Bracci B;Muscogiuri E;De Dominicis C;Laghi A
通讯作者:
Laghi A